i
Emergence of SARS-COV-2 Spike Protein Escape Mutation Q493R after Treatment for COVID-19
-
10 2021
Source: Emerg Infect Dis. 27(10):2728-2731 -
Alternative Title:Emerg Infect Dis
-
Personal Author:
-
Description:We report in vivo selection of a severe acute respiratory syndrome coronavirus 2 spike mutation (Q493R) conferring simultaneous resistance to bamlanivimab and etesivimab. This mutation was isolated from a patient who had coronavirus disease and was treated with these drugs.
-
Subjects:
-
Pubmed ID:34314668
-
Pubmed Central ID:PMC8462334
-
Document Type:
-
Collection(s):
-
Main Document Checksum:
-
File Type: